CSAM Health Group AS (OB:CSAM) commences an Equity Buyback Plan under the authorization approved on May 19, 2022.
January 30, 2023 at 06:43 am EST
Share
CSAM Health Group AS (OB:CSAM) commences share repurchases on January 20, 2023, under the program mandated by the shareholders in the Annual General Meeting held on May 19, 2022. As per the mandate, the company is authorized to repurchase its own shares, such that the nominal value of the shares which the company may acquire in total may not exceed NOK 0.21 million. The minimum price which may be paid for each ordinary share is NOK 30 per share and the maximum price is NOK 130 per share. The authorization may be used as a financial instrument, by the board of directors being able to make use of liquidity to acquire shares in the Company, or may be used in connection with acquisitions or other transactions where the Company is to render consideration as shares The program is valid till May 18, 2024. As of May 19, 2022, the company had 20,967,404 shares outstanding with no shares in treasury.
On June 27, 2022, the company announced a share repurchase program. Under the program, the company will repurchase 333,333 of its own shares, for NOK 20 million. The maximum price to be paid per share under the program is NOK 60. Shares acquired as part of the buyback program are primarily intended to be used as consideration in future acquisitions by the company. Any shares purchased will be held in treasury until used for the above purposes. The repurchases will be conducted in the period from June 27, 2022 until and including December 31, 2022.
On November 30, 2022, the company announced a share repurchase program. Under the program, the company will repurchase 666,666 of its own shares, for NOK 20 million. The maximum price to be paid per share under the program is NOK 60. Shares acquired as part of the buyback program are primarily intended to be used as consideration in future acquisitions by the company. Any shares purchased will be held in treasury until used for the above purposes. The repurchases will be conducted in the period from November 30, 2022, until and including the day before the Issuer?s Annual General Meeting in 2023, or until the maximum number of shares have been repurchased.
On May 3, 2023, the company extended the plan duration till the day before the Company?s Annual General Meeting in 2024.
Omda AS, formerly known as CSAM HEALTH GROUP AS, is a Norway-based provider of specialised software for healthcare sector. Its specialized software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. The Companyâs product portfolio includes solutions in public safety, connected healthcare, women and children's health, laboratory information management systems, medical imaging, medication management, and health analytics. Its headquartered in Oslo, Norway with local offices in Sweden, Denmark, Finland, UK, Lithuania, Spain, New Zealand, the United States and the Philippines. The Company delivers software and services to almost all hospitals in the Nordic region.
OMDA 
